Komori
Kirin Holdings (2503) · InitiativeFirst stated

Support for Rare and Intractable Diseases through Patient Advocacy

First written in FY2022. . Latest entry: FY2022.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Support for Rare and Intractable Diseases through Patient AdvocacyA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022First statedAnnual report

    「また、病気と向き合う人の声を聞き、事業と社会課題の解決を目指す「ペイシェント・アドボカシー」活動では、特定非営利活動法人ASrid等各国の患者支援団体と協力し、希少・難治性疾患の支援を国内外で積極的に進めました。」

    医薬事業において、患者の声を踏まえた事業活動と社会課題解決を結び付け、国内外の患者支援団体との協力を開始・推進した。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kirin Holdings's next results are scheduled for 2026-11-11. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.